Simultaneous Determination of Aceclofenac, Paracetamol and Chlorzoxazone by HPLC in Tablet Dose Form

Similar documents
Simultaneous HPLC Determination of Methocarbamol, Paracetamol and Diclofenac Sodium

Simultaneous Determination of Paracetamol, Chlorzoxazone and Diclofenac Sodium in Tablet Dosage Form by High Performance Liquid Chromatography

SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND PARACETAMOL IN SUSPENSION FORM BY USING UPLC

Pelagia Research Library

RP-HPLC Estimation of Trospium Chloride in Tablet Dosage Forms

Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form

International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010

Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD

Development and Validation of a HPLC Method for Determination of Anastrozole in Tablet Dosage Form

Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form

SIMULTANEOUS RP HPLC DETERMINATION OF CAMYLOFIN DIHYDROCHLORIDE AND PARACETAMOL IN PHARMACEUTICAL PREPARATIONS.

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

A Simple, Novel Validated Stability Indicating RP-HPLC method for estimation of Duloxetine HCl in Capsule Pharmaceutical Formulation

J Pharm Sci Bioscientific Res (4): ISSN NO

Method Development and Validation Of Prasugrel Tablets By RP- HPLC

Impact factor: 3.958/ICV: 4.10 ISSN:

Research Article METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR BY RP-HPLC

RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation

CHAPTER 19 PARACETAMOL + IBUPROFEN

Department of Quality Assurance, Luqman College of Pharmacy, GULBARGA (K.S.) INDIA ABSTRACT

Development and Statistical Validation of Spectrophotometric Methods for the Estimation of Nabumetone in Tablet Dosage Form

UV Spectrophotometric Estimation of Levoceterizine Dihydrochloride in Bulk and Dosage Form

Scholars Research Library

Development of Validated Analytical Method of Mefenamic Acid in an Emulgel (Topical Formulation)

Research Article. Simultaneous spectrophotometric estimation of Paracetamol and Aceclofenac by second order derivative method in combined dosage form

Impact factor: 3.958/ICV: 4.10 ISSN:

DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF AFLOQUALONE IN HUMAN PLASMA AND FORMULATION

RP-HPLC method for simultaneous estimation of amoxicillin and carbocisteine in dosage forms

METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS

Development and validation a RP-HPLC method: Application for the quantitative determination of quetiapine fumarate from marketed bulk tablets

Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form

International Journal of Pharma and Bio Sciences V1(1)2010. HPLC method for analysis of Lercanidipine Hydrochloride in Tablets

Method Development and Validation for the Estimation of Darunavir in Rat Plasma by RP-HPLC

Stability Indicating RP-HPLC Method for Determination of Drotaverine HCL and Mefenamic Acid in Pure and Pharmaceutical Formulation

Spectrophotometric Determination of Lorsartan Potassium and its Dosage Form by Bromothymol Blue and Phosphate Buffer

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

Analytical Method Development and Validation of Lafutidine in Tablet dosage form by RP-HPLC

KEYWORDS: Acetaminophen, Doxylamine succinate, Dextromethorphan hydrobromide.

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION

JMSCR Volume 03 Issue 03 Page March 2015

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Zero And First Order Derivative Spectrophotometric Methods For Determination Of Dronedarone In Pharmaceutical Formulation

Chapter 4: Verification of compendial methods

Development and validation of RP-LC method for lisinopril dihydrate in bulk and its pharmaceutical formulations

International Journal of Pharma Research and Health Sciences. Available online at

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Received: ; Accepted:

STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF GABAPENTIN IN PURE AND PHARMACEUTICAL FORMULATIONS

Stability Indicating RP-HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation

CHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Stability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form

UV Spectrophotometric Method for the Estimation of Itopride Hydrochloride in Pharmaceutical Formulation

ISSN: ; CODEN ECJHAO E-Journal of Chemistry , 9(1), 35-42

RP-HPLC Method for the Determination of Cinitapride in the Presence of its Degradation Products in Bulk Drug

Vol - 4, Issue - 3, Supl - 1 Apr-Jul 2013 ISSN: Patel et al PHARMA SCIENCE MONITOR

Pharmacophore 2011, Vol. 2 (4), ISSN Pharmacophore. (An International Research Journal)

STABILITY INDICATING RP HPLC METHOD FOR ANALYSIS OF DORZOLAMIDE HCl IN THE BULK DRUG AND IT S PHARMACEUTICAL DOSAGE FORM

Simultaneous Estimation Of Paracetamol And Pamabrom Inbulk Drugs And In Pharmaceutical Formulation By Spectrophotometry

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Estimation of zaleplon by a new RP-HPLC method

Determination of Fexofenadine Hydrochloride in Pharmaceutical Dosage Form By Reverse Phase High Performance Liquid Chromatography Method

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Novus International Journal of Analytical Innovations 2012, Vol. 1, No. 3

Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

Journal of Chemical and Pharmaceutical Research

A Reverse Phase Liquid Chromatography Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

Received: ; Accepted:

Simultaneous Spectrophotometric Estimation of Aceclofenac and Paracetamol

Development and Validation of Stability-Indicating RP-HPLC Method for Estimation of Atovaquone

Research Article. Validated HPTLC method for simultaneous estimation of Aceclofenac and Pantoprazole in bulk and tablets dosage form

A NEW HPLC METHOD FOR THE QUANTIFICATION OF PANTOPRAZOLE IN PHARMACEUTICALS

Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune , India

Asian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page:

A VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND DICLOFENAC POTASSIUM IN PHARMACEUTICAL FORMULATION

RP-HPLC Method for the Estimation of Nebivolol in Tablet Dosage Form

Volume 6, Issue 2, January February 2011; Article-015

Journal of Chemical and Pharmaceutical Research

Research Article Available online at

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article

4.1 MATERIALS 4.2 EQUIPMENTS

Vol-3, Issue-4, Suppl-1, Nov 2012 ISSN: Solanki et al PHARMA SCIENCE MONITOR

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)

Chapter-4 EXPERIMENTAL WORK BY RP-HPLC

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

Journal of Chemical and Pharmaceutical Research

Low-level Determination of 4-Hydrazino Benzoic Acid in Drug Substance by High Performance Liquid Chromatography/Mass Spectrometry

ANALYTICAL METHOD PROCEDURES

Development and validation of stability indicating reverse phase high performance liquid chromatography method for Timolol Maleate

Development and Validation of a HPLC Method for Chlorphenamine Maleate Related Substances in Multicomponents Syrups and Tablets

Rapid and simultaneous determination of paracetamol, ibuprofen and related impurity of ibuprofen by UPLC/DAD

Development and Validation of Sensitive RP-HPLC Method for the Estimation of Glibenclamide in Pure and Tablet Dosage Forms

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

RP - HPLC METHOD FOR ESTIMATION OF PARACETAMOL FROM PHARMACEUTICAL FORMULATION FEBRINIL

Transcription:

ISSN: 0973-4945; CDEN ECJHA E- Chemistry http://www.e-journals.net 2009, 6(1), 289-294 Simultaneous Determination of Aceclofenac, Paracetamol and Chlorzoxazone by HPLC in Tablet Dose Form UTTAM D. PAWAR, ABHIJIT V.NAIK, ARUNA V. SULEBHAVIKAR #, TIRUMAL A. DATAR and KIRAN.V. MANGANKAR * Department of Chemistry, Mithibai College of Arts, Chauhan Institute of Science & Amrutben Jivanlal College of Commerce and Economics, Vile Parle (W), Mumbai- 400 056, India. # Department of Chemistry, K. J. Somaiya Senior College of Science and Commerce, Vidyanagar, Vidyavihar, Mumbai-400077, India uttamar@indiatimes.com Received 11 May 2008; Accepted 5 July 2008 Abstract: A simple, fast and precise reversed phase high performance liquid chromatographic method is developed for the simultaneous determination of aceclofenac, paracetamol and chlorzoxazone. Chromatographic separation of the three drugs was performed on an Intersil C 18 column (250 mm x 4.6 mm, 5 µm) as stationary phase with a mobile phase comprising of 10 mm potassium dihydrogen phosphate (ph adjusted to 5.55 with ammonia): acetonitrile in the ratio 60:40 (v/v) at a flow rate of 1.0 ml/min and UV detection at 205 nm. The linearity of aceclofenac, paracetamol and chlorzoxazone were in the range of 5.00-15.00 µg/µl, 25.00-75.00 µg/µl and 25.00-75.00 µg/µl respectively. The limit of detection for aceclofenac, paracetamol and chlorzoxazone was found to be 18.0 ng/ml, 22.0 ng/ml and 9.0 ng/ml respectively whereas, the limit of quantification was found to be 55 ng/ml, 65 ng/ml and 27.0 ng/ml respectively. The recovery was calculated by standard addition method. The average recovery was found to be 99.04%, 99.57% and 101.63% for aceclofenac, paracetamol and chlorzoxazone respectively. The proposed method was found to be accurate, precise and rapid for the simultaneous determination of aceclofenac, paracetamol and chlorzoxazone. Keywords: HPLC, Aceclofenac, Paracetamol, Chlorzoxazone, Tablet

290 KIRAN.V. MANGANKAR et al. Introduction Aceclofenac (Molecular formula: C 16 H 13 Cl 2 N 4 ; Molecular weight: 354.19) 1,2, 2-[2-[2-(2, 6- dichlorophenyl) aminophenyl] acetyl] oxyacetic acid is a highly effective anti-inflammatory drug. It has been widely used for the treatment of arthritis. It works by blocking the action of a substance in the body called cyclooxygenase. Cyclooxygenase is involved in the production of various chemicals in the body, some of which are known as prostaglandin. Paracetamol (Molecular formula: C 8 H 9 N 2 ; Molecular weight: 151.16) 1,2, N- (4-hydroxyphenyl) acetamide is a well known analgesic drug, which is very effective treatment for the relief of pain and fever in adults and children. Paracetamol is mostly converted to inactive compounds via Phase II metabolism by conjugation with sulfate and glucuronide, with a small portion being oxidised via the cytochrome P450 enzyme system. Cytochrome P450 2E1 (CYP2E1) converts paracetamol to a highly reactive intermediary metabolite, N-acetyl-p-benzoquinone imine (NAPQI). Chlorzoxazone (Molecular formula: C 7 H 4 ClN 2 ; Molecular weight: 169.57) 1,2, 5- chloro-2-benzoxazolone is a effective muscle relaxant. Chlorzoxazone is a centrally acting agent for painful musculoskeletal conditions. Chlorzoxazone acts primarily at the level of the spinal cord and sub cortical areas of the brain where it inhibits multisynaptic reflex action involved in producing and maintaining skeletal muscle spasm of varied etiology. The structural formuls 1, 2 of these three drugs are shown in Figure 1. CH Cl NH Cl Cl H N H H N 1. Aceclofenac 2. Chlorzoxazone. 3. Paracetamol. Figure 1. The structural formulas In this paper we have reported an HPLC method for simultaneous determination of one such combination contains 100 mg aceclofenac, 500 mg Paracetamol and 500 mg chlorzoxazone. This method was developed and optimized by following ICH tripartite guidelines 3. The literature reveals single HPLC 4 and two HPTLC 5,6 methods reported for simultaneous determination in combination with other analgesic drug and no method was available for simultaneous determination of all these three drugs in such pharmaceutical preparations by HPLC. Therefore an RP-HPLC method was developed for determination of aceclofenac, paracetamol and chlorzoxazone from their combined dosage form. The method described is simple, fast, precise and accurate for simultaneous determination of aceclofenac, paracetamol and chlorzoxazone from pharmaceutical preparation. Experimental Working standards and chemicals The formulation, Hifenac MR Tablets (containing 100 mg of aceclofenac, 500 mg of paracetamol and 500 mg of chlorzoxazone) were procured from pharmacies. All working standards were obtained from TDM Labs. Sion, Mumbai with certificate of analysis. Toluene, acetonitrile, methanol and glacial acetic acid used were analytical grade. All dilutions were performed in standard volumetric flasks.

Simultaneous Determination of Aceclofenac, Paracetamol 291 Instrument Chromatographic separation was preformed with Jasco high performance liquid chromatography having PU-980 HPLC isocratic pump, equipped with Jasco AS-2057 auto sampler and a Jasco UV- 970 variable wavelength detector. Chromatograms and data were recorded by means of Borwin Chromatographic software version 1.21. Working standard solution preparation 25 mg of aceclofenac (99.20 %) was taken in a 25 ml volumetric flask. This was dissolved in minimum quantity of methanol and diluted up to the mark to get a concentration 1000 µg/ml of aceclofenac. Similarly stock solutions of 1000 µg/ml of each paracetamol (100.31%) and chlorzoxazone (99.28%) were prepared in 25 ml volumetric flasks using methanol. ptimized chromatographic conditions 10 mm Potassium dihydrogen phosphate at ph 5.55 (±0.05) with ammonia and acetonitrile in the volume of ratio 60:40 v/v. Analytical column: Intersil C 18 column (250 mm x 4.6 mm) 5 µ UV detection: 205 nm Flow rate: Injection volume: 10 µl Temperature: Run time: Retention time: 1.00 ml/min Ambient 25.0 min (A) Paracetamol ~ 3.40 min (B) Chlorzoxazone ~ 11.25 min (C) Aceclofenac ~ 19.48 min Linearity of detector response Solution containing mixture of aceclofenac, paracetamol and chlorzoxazone of six different concentrations were prepared in mobile phase in 10 ml volumetric flasks from stock solution. The concentration range for each of the three drugs in the linearity working standard solutions were 5.00 to 15.00 µg/ml for aceclofenac, 25.0 to 75.0 µg/ml for paracetamol and 25.0 to 75.0 µg/ml for chlorzoxazone were prepared. 10 µl of each solution was injected in three replicates. The chromatograms were recorded and the peak areas were computed. A typical HPLC chromatogram is shown in Figure 2. A linear relationship between peak areas (average peak areas of three replicates) versus concentrations was observed for aceclofenac, paracetamol and chlorzoxazone in the above linearity range. This range was selected as linear range for analytical method development of three components. Sample preparation Twenty tablets were weighed and average weight was calculated. These tablets were powdered. Weighed equivalent to one tablet was taken in a 100 ml volumetric flask; dissolved in minimum amount methanol and diluted up to the mark with methanol. That solution was then filtered through Whatman s filer paper no. 41 and the filtrate was collected in the flask. ne ml of that filtrate was diluted to 100 ml with mobile phase to get 10.00 µg/ml of aceclofenac, 50.00 µg/ml of paracetamol and 50.00 µg/ml of chlorzoxazone.

292 KIRAN.V. MANGANKAR et al. Paracetamol (R t =3.40), Chlorzoxazone (R t =11.25) and Aceclofenac (R t =19.48) Figure 2. Typical HPLC chromatogram. Assay From the above sample solution 10 µl was spotted in triplicate along with same concentration of standard solution on to the plate under the optimized chromatographic conditions. The peak area values of aceclofenac, paracetamol, and chlorzoxazone were calculated. The amount of aceclofenac, paracetamol, and chlorzoxazone present in that solution were then estimated using calibration curve method. Results of assay are tabulated in Table 1. Table 1. Results of assay experiment. Drug Labeled claim, mg Amount found (n=7) % CV % Assay Aceclofenac 100 99.04 1.88 99.04 Paracetamol 500 497.87 1.23 99.57 Chlorzoxazone 500 508.16 0.70 101.63 Recovery studies Recovery experiments were carried out to check for the presence of positive or negative interferences from excipients present in the formulation and to study the accuracy and precision of the method. Recovery experiment was performed by the standard addition method 3. The recovery of the added standard was studied at three different levels viz 120%, 140% and 160% of the estimated amount of the drug. Each set of recovery of added standard was calculated. The results of recovery experiment are tabulated in Table 2A, 2B and 2C. The limit of quantitation (LQ) and limit of detection (LD) The limit of quantitation (LQ) and limit of detection (LD) was established at a signal-tonoise ratio. The LD and LQ of aceclofenac, paracetamol and chlorzoxazone were experimentally determined by six injections of each drug. The LD of aceclofenac, paracetamol and chlorzoxazone were found to be 18 ng/ml, 22 ng/ml and 9 ng/ml respectively. The LQ of aceclofenac, paracetamol and chlorzoxazone were found to be 55 ng/ml, 65 ng/ml and 27 ng/ml respectively.

Simultaneous Determination of Aceclofenac, Paracetamol 293 Table 2. Results of recovery experiments (A, B, C). Aceclofenac (A) Amount of Aceclofenac in 'mg' S. No. % riginal Added Total Mean SD %CV % Added amount amount amount (n=5) Recovery 1 0.0 100.00 0.00 100.00 101.16 0.92 0.91 101.16 2 20.0 100.00 20.00 120.00 120.26 1.48 1.23 100.22 3 40.0 100.00 40.00 140.00 137.16 1.49 1.09 97.97 4 60.0 100.00 60.00 160.00 159.80 2.59 1.62 99.88 Average Total 99.81 Paracetamol (B) Amount of Paracetamol in 'mg' S. No. % riginal Added Total Mean SD %CV %Recovery Added amount amount amount (n=5) 1 0.0 500.00 0.00 500.00 506.80 5.93 1.17 101.36 2 20.0 500.00 100.00 600.00 602.80 9.93 1.65 100.47 3 40.0 500.00 200.00 700.00 707.60 9.66 1.37 101.09 4 60.0 500.00 300.00 800.00 810.00 10.86 1.34 101.25 Average Total 101.04 Chlorzoxazone (C) Amount of Chlorzoxazone in 'mg' S. No. % riginal Added Total Mean SD %CV %Recovery Added amount amount amount (n=5) 1 0.0 500.00 0.00 500.00 500.80 9.36 1.87 100.16 2 20.0 500.00 100.00 600.00 593.60 7.47 1.26 98.93 3 40.0 500.00 200.00 700.00 709.00 7.68 1.08 101.29 4 60.0 500.00 300.00 800.00 809.00 10.15 1.25 101.13 Average Total 100.38 ( n each value is average of five determinations) Results and Discussion The Reverse Phase High Performance Liquid Chromatography method was optimized with a view to developed a stability indicating assay method. Pure drugs chromatogram was run in different mobile phases containing methanol, acetonitrile, water and different buffers in different ratios. Different columns (e.g. C 8, C 18, phenyle) with different dimentions were used. The retention time and tailing factor was calculated for each drugs and for each chromatogram. Finally 10 mm potassium dihydrogen phosphate at ph 5.55 (±0.05) with ammonia and acetonitrile as a mobile phase in the volume of ratio 60:40 v/v and Intersil C 18 analytical column was selected which gave a sharp and symmetrical peak with minimum tailing. Calibration graph was found to be linear at range 5.00 to 150.00 µg/ml, 25.00 to 75.00 µg/ml and 25.00 to 75.00 µg/ml for the aceclofenac, paracetamol and chlorzoxazone respectively. Six different concentrations of a mixture of three drugs in the range given above were prepared and 10 µl of each solution injected in HPLC. Regression analysis of the calibration data for aceclofenac, paracetamol and chlorzoxazone showed that the dependent variable (peak area) and the independent variable (concentration) were represented by the equations:

294 KIRAN.V. MANGANKAR et al. y = m x + c was found to y = 146852 x + (0), y = 139836.7 x + (-620986) and y = 226994.3 x + 7266174 for aceclofenac, paracetamol and chlorzoxazone respectively. The correlation of coefficient (r 2 ) obtained was found to be 0.9984, 0.9988 and 0.9990 for aceclofenac, paracetamol and chlorzoxazone respectively. It was observed that the concentration range showed a good relationship. The limit of detection for aceclofenac, paracetamol and chlorzoxazone were found to be 18 ng/ml, 22 ng/ml and 9 ng/ml respectively and the limit of quantification was found to be 55 ng/ml, 65 ng/ml and 27 ng/ml respectively. It proves the sensitivity of method for the drugs. The % assay or average amount of aceclofenac, paracetamol, and chlorzoxazone found to be 99.04%, 99.57% and 101.63% respectively in each tablet. The average % recovery for aceclofenac, paracetamol and chlorzoxazone was found to be 99.81%, 101.04% and 100.38% respectively which shows that method is free from interference from excipients present in the formulation. The low values of standard deviation and coefficient of variation at each level of the recovery experiment indicate high precision of the method. Conclusion The high performance liquid chromatographic method for the determination of aceclofenac, paracetamol and chlorzoxazone from their fixed dosage form was found to be accurate and precise. Thus, the proposed HPLC method can be successfully applied for the routine quality control analysis of aceclofenac, paracetamol and chlorzoxazone from their fixed dosage form. Acknowledgment We thank Ramnarain Ruia College and TDM Labs for technical assistance in conducting this study. We gratefully acknowledge the excellent cooperation of Dr. R. T. Sane, Dr. Vikas Vaidya and Ms Nutan Prabhu-Navelkar. References 1. Susan Budavari, Maryadele J Neil, Ann Smith, Patricia E, Heckelman, Joanne F and Kinneary, The Merck Index, Merck Research Laboratories, 13 rd Ed., 2001. 2. George Lunn, HPLC methods for pharmaceutical analysis, 1999, 2, 5, 367. 3. ICH Q2A, Text on validation of analytical procedures, International Conference on Harmonization tripartite guidelines, adapted 27 ct 1994B. 4. Gopinath R, Rajan S, Meyyanthan S N, Krishnaveni N and Suresh B A, J Pharma Sci., 2007, 69, 137. 5. Fried J and Sherma, Thin Layer Chromatography, 4 th Ed., 1994. 81, New York, 1994. 6. Ramesh T, Sane and Manjusha Gadgil, J Planar Chromatogr- Mod TLC, 2002, 15, 76.

International Medicinal Chemistry Photoenergy International rganic Chemistry International International Analytical Chemistry Advances in Physical Chemistry International Carbohydrate Chemistry Quantum Chemistry Submit your manuscripts at The Scientific World Journal International Inorganic Chemistry Theoretical Chemistry Catalysts International Electrochemistry Chromatography Research International Spectroscopy Analytical Methods in Chemistry Applied Chemistry Bioinorganic Chemistry and Applications International Chemistry Spectroscopy